This inventor holds 2 USPTO granted patents. Top assignee: Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Haijian Ding: Innovator in Pharmaceutical Research
Introduction
Haijian Ding is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibodies. His work is recognized for its potential impact on medical treatments and therapies.
Latest Patents
Haijian Ding holds a patent for "Sequences of anti-ecto-5'-nucleotidase antibodies." This innovation is crucial in advancing therapeutic options for various medical conditions. He has 1 patent to his name, showcasing his commitment to research and development in the pharmaceutical industry.
Career Highlights
Ding is currently employed at Jiangsu Kanion Pharmaceutical Co., Ltd. This company is known for its dedication to pharmaceutical innovation and research. His role at the company allows him to work on cutting-edge projects that aim to improve healthcare outcomes.
Collaborations
Throughout his career, Haijian Ding has collaborated with notable colleagues, including Gaoyong Liao and Ling Wang. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Haijian Ding is a dedicated inventor whose work in pharmaceutical research is paving the way for new medical advancements. His contributions, particularly in antibody development, highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile